Insights into potential therapeutic approaches for long COVID

References

[1] Al-Aly Z , Xie Y , Bowe B . High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021; 594(7862): 259–264

[2] Davis HE , McCorkell L , Vogel JM , Topol EJ . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21(3): 133–146

[3] Nittas V , Gao M , West EA , Ballouz T , Menges D , Wulf Hanson S , Puhan MA . Long COVID through a public health lens: an umbrella review. Public Health Rev 2022; 43: 1604501

[4] Venkatesan P . NICE guideline on long COVID. Lancet Respir Med 2021; 9(2): 129

[5] Al-Aly Z , Bowe B , Xie Y . Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022; 28(7): 1461–1467

[6] Haffke M , Freitag H , Rudolf G , Seifert M , Doehner W , Scherbakov N , Hanitsch L , Wittke K , Bauer S , Konietschke F , Paul F , Bellmann-Strobl J , Kedor C , Scheibenbogen C , Sotzny F . Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med 2022; 20(1): 138

[7] Charfeddine S , Ibn Hadj Amor H , Jdidi J , Torjmen S , Kraiem S , Hammami R , Bahloul A , Kallel N , Moussa N , Touil I , Ghrab A , Elghoul J , Meddeb Z , Thabet Y , Kammoun S , Bouslama K , Milouchi S , Abdessalem S , Abid L . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med 2021; 8: 745758

[8] Puntmann VO , Carerj ML , Wieters I , Fahim M , Arendt C , Hoffmann J , Shchendrygina A , Escher F , Vasa-Nicotera M , Zeiher AM , Vehreschild M , Nagel E . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5(11): 1265–1273

[9] Bitirgen G , Korkmaz C , Zamani A , Ozkagnici A , Zengin N , Ponirakis G , Malik RA . Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br J Ophthalmol 2022; 106(12): 1635–1641

[10] Rutkai I , Mayer MG , Hellmers LM , Ning B , Huang Z , Monjure CJ , Coyne C , Silvestri R , Golden N , Hensley K , Chandler K , Lehmicke G , Bix GJ , Maness NJ , Russell-Lodrigue K , Hu TY , Roy CJ , Blair RV , Bohm R , Doyle-Meyers LA , Rappaport J , Fischer T . Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 2022; 13(1): 1745

[11] Bateman L , Bested AC , Bonilla HF , Chheda BV , Chu L , Curtin JM , Dempsey TT , Dimmock ME , Dowell TG , Felsenstein D , Kaufman DL , Klimas NG , Komaroff AL , Lapp CW , Levine SM , Montoya JG , Natelson BH , Peterson DL , Podell RN , Rey IR , Ruhoy IS , Vera-Nunez MA , Yellman BP . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc 2021; 96(11): 2861–2878

[12] Yu JZ , Granberg T , Shams R , Petersson S , Sköld M , Nyrén S , Lundberg J . Lung perfusion disturbances in nonhospitalized post-COVID with dyspnea—a magnetic resonance imaging feasibility study. J Intern Med 2022; 292(6): 941–956

[13] Vijayakumar B , Boustani K , Ogger PP , Papadaki A , Tonkin J , Orton CM , Ghai P , Suveizdyte K , Hewitt RJ , Desai SR , Devaraj A , Snelgrove RJ , Molyneaux PL , Garner JL , Peters JE , Shah PL , Lloyd CM , Harker JA . Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 2022; 55(3): 542–556. e5

[14] Ding T , Wang T , Zhang J , Cui P , Chen Z , Zhou S , Yuan S , Ma W , Zhang M , Rong Y , Chang J , Miao X , Ma X , Wang S . Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front Med (Lausanne) 2021; 8: 635255

[15] Dennis A , Wamil M , Alberts J , Oben J , Cuthbertson DJ , Wootton D , Crooks M , Gabbay M , Brady M , Hishmeh L , Attree E , Heightman M , Banerjee R , Banerjee A . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11(3): e048391

[16] Bowe B , Xie Y , Xu E , Al-Aly Z . Kidney outcomes in long COVID. J Am Soc Nephrol 2021; 32(11): 2851–2862

[17] Meringer H , Mehandru S . Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol 2022; 19(6): 345–346

[18] Peluso MJ , Deeks SG . Mechanisms of long COVID and the path toward therapeutics. Cell 2024; 187(20): 5500–5529

[19] Dillen H , Bekkering G , Gijsbers S , Vande Weygaerde Y , Van Herck M , Haesevoets S , Bos DAG , Li A , Janssens W , Gosselink R , Troosters T , Verbakel JY . Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review. BMC Infect Dis 2023; 23(1): 419

[20] McGregor G , Sandhu H , Bruce J , Sheehan B , McWilliams D , Yeung J , Jones C , Lara B , Alleyne S , Smith J , Lall R , Ji C , Ratna M , Ennis S , Heine P , Patel S , Abraham C , Mason J , Nwankwo H , Nichols V , Seers K , Underwood M . Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial. BMJ 2024; 384: e076506

[21] Elyazed TIA , Alsharawy LA , Salem SE , Helmy NA , El-Hakim A . Effect of home-based pulmonary rehabilitation on exercise capacity in post COVID-19 patients: a randomized controlled trail. J Neuroeng Rehabil 2024; 21(1): 40

[22] Spiesshoefer J , Regmi B , Senol M , Jörn B , Gorol O , Elfeturi M , Walterspacher S , Giannoni A , Kahles F , Gloeckl R , Dreher M . Potential diaphragm muscle weakness-related dyspnea persists 2 years after COVID-19 and could be improved by inspiratory muscle training: results of an observational and an interventional clinical trial. Am J Respir Crit Care Med 2024; 210(5): 618–628

[23] Palacios-Ceña D , Bautista-Villaécija O , Güeita-Rodríguez J , García-Bravo C , Pérez-Corrales J , Del Corral T , López-de-Uralde-Villanueva I , Fabero-Garrido R , Plaza-Manzano G . Supervised telerehabilitation and home-based respiratory muscle training for post-COVID-19 condition symptoms: a nested qualitative study exploring the perspectives of participants in a randomized controlled trial. Phys Ther 2024; 104(5): pzae043

[24] Parker M , Sawant HB , Flannery T , Tarrant R , Shardha J , Bannister R , Ross D , Halpin S , Greenwood DC , Sivan M . Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome. J Med Virol 2023; 95(1): e28373

[25] Hwang SH , Kim SW , Basurrah MA , Kim DH . The efficacy of olfactory training as a treatment for olfactory disorders caused by coronavirus disease-2019: a systematic review and meta-analysis. Am J Rhinol Allergy 2023; 37(4): 495–501

[26] Tryfonos A , Pourhamidi K , Jörnåker G , Engvall M , Eriksson L , Elhallos S , Asplund N , Mandic M , Sundblad P , Sepic A , Rullman E , Hyllienmark L , Rundqvist H , Lundberg TR , Gustafsson T . Functional limitations and exercise intolerance in patients with post-COVID condition: a randomized crossover clinical trial. JAMA Netw Open 2024; 7(4): e244386

[27] Wright J , Astill SL , Sivan M . The relationship between physical activity and long COVID: a cross-sectional study. Int J Environ Res Public Health 2022; 19(9): 5093

[28] Yotsuyanagi H , Ohmagari N , Doi Y , Yamato M , Fukushi A , Imamura T , Sakaguchi H , Sonoyama T , Sanaki T , Ichihashi G , Tsuge Y , Uehara T , Mukae H . Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial. Antiviral Res 2024; 229: 105958

[29] Xie Y , Choi T , Al-Aly Z . Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ 2023; 381: e074572

[30] Xie Y , Choi T , Al-Aly Z . Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med 2023; 183(6): 554–564

[31] Xie Y , Bowe B , Al-Aly Z . Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records. BMJ 2023; 381: e073312

[32] Gottlieb RL , Vaca CE , Paredes R , Mera J , Webb BJ , Perez G , Oguchi G , Ryan P , Nielsen BU , Brown M , Hidalgo A , Sachdeva Y , Mittal S , Osiyemi O , Skarbinski J , Juneja K , Hyland RH , Osinusi A , Chen S , Camus G , Abdelghany M , Davies S , Behenna-Renton N , Duff F , Marty FM , Katz MJ , Ginde AA , Brown SM , Schiffer JT , Hill JA . Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 2022; 386(4): 305–315

[33] Hobbs FR , Gbinigie-Thompson OA , Shanyinde M , Yu LM , Harris V , Dorward J , Hayward G , Saville BR , Berry NS , Evans PH , Thomas NP , Patel MG , Richards D , Hecke OV , Detry MA , Saunders CT , Fitzgerald M , Robinson J , Latimer-Bell C , Allen J , Ogburn E , Grabey J , de Lusignan S , Andersson M , Little P , Butler CC . Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes. J Infect 2024; 89(4): 106248

[34] Greenhalgh T , Sivan M , Perlowski A , Nikolich JŽ . Long COVID: a clinical update. Lancet 2024; 404(10453): 707–724

[35] Bolton MJ , Chapman BP , Van Marwijk H . Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Rep 2020; 13(1): e232502

[36] Pitt B , Tate AM , Gluck D , Rosenson RS , Goonewardena SN . Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. Eur Heart J Cardiovasc Pharmacother 2022; 8(4): 402–405

[37] Wang C , Yu C , Jing H , Wu X , Novakovic VA , Xie R , Shi J . Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol 2022; 12: 861703

[38] Tölle M , Freitag H , Antelmann M , Hartwig J , Schuchardt M , van der Giet M , Eckardt KU , Grabowski P , Scheibenbogen C . Myalgic encephalomyelitis/chronic fatigue syndrome: efficacy of repeat immunoadsorption. J Clin Med 2020; 9(8): 2443

[39] Alper K . Case report: famotidine for neuropsychiatric symptoms in COVID-19. Front Med (Lausanne) 2020; 7: 614393

[40] Kikkenborg Berg S , Dam Nielsen S , Nygaard U , Bundgaard H , Palm P , Rotvig C , Vinggaard Christensen A . Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health 2022; 6(4): 240–248

[41] Goel N , Goyal N , Nagaraja R , Kumar R . Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis 2021; 92(2): 10.4081/monaldi.2021.1981

[42] Gheorghita R , Soldanescu I , Lobiuc A , Caliman Sturdza OA , Filip R , Constantinescu-Bercu A , Dimian M , Mangul S , Covasa M . The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches. Front Immunol 2024; 15: 1344086

[43] Lukkunaprasit T , Satapornpong P , Kulchanawichien P , Prawang A , Limprasert C , Saingam W , Permsombut C , Panidthananon W , Vutthipong A , Lawanprasert Y , Pourpongpan P , Wongwiwatthananukit S , Songsak T , Pradubyat N . Impact of combined plant extracts on long COVID: an exploratory randomized controlled trial. Complement Ther Med 2024; 87: 103107

[44] Saab AM , Tacchini M , Sacchetti G , Contini C , Schulz H , Lampronti I . Phytochemical analysis and potential natural compounds against SARS-CoV-2/COVID-19 in essential oils derived from medicinal plants originating from Lebanon. An information note. Plant Biosyst 2021; 156: 2022

[45] Crucianelli S , Mariano A , Valeriani F , Cocomello N , Gianfranceschi G , Baseggio Conrado A , Moretti F , Scotto d’Abusco A , Mennuni G , Fraioli A , Del Ben M , Romano Spica V , Fontana M . Effects of sulphur thermal water inhalations in long-COVID syndrome: Spa-centred, double-blinded, randomised case-control pilot study. Clin Med (Lond) 2024; 24(6): 100251

[46] Currie C , Myklebust T , Bjerknes C , Framroze B . Assessing the potential of an enzymatically liberated salmon oil to support immune health recovery from acute SARS-CoV-2 infection via change in the expression of cytokine, chemokine and interferon-related genes. Int J Mol Sci 2024; 25(13): 6917

[47] Ho WY , Shen ZH , Chen Y , Chen TH , Lu X , Fu YS . Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic. Heliyon 2024; 10(9): e30080

[48] Bramante CT , Buse JB , Liebovitz DM , Nicklas JM , Puskarich MA , Cohen K , Belani HK , Anderson BJ , Huling JD , Tignanelli CJ , Thompson JL , Pullen M , Wirtz EL , Siegel LK , Proper JL , Odde DJ , Klatt NR , Sherwood NE , Lindberg SM , Karger AB , Beckman KB , Erickson SM , Fenno SL , Hartman KM , Rose MR , Mehta T , Patel B , Griffiths G , Bhat NS , Murray TA , Boulware DR; COVID-OUT Study Team . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis 2023; 23(10): 1119–1129

[49] Bronte V , Ugel S , Tinazzi E , Vella A , De Sanctis F , Canè S , Batani V , Trovato R , Fiore A , Petrova V , Hofer F , Barouni RM , Musiu C , Caligola S , Pinton L , Torroni L , Polati E , Donadello K , Friso S , Pizzolo F , Iezzi M , Facciotti F , Pelicci PG , Righetti D , Bazzoni P , Rampudda M , Comel A , Mosaner W , Lunardi C , Olivieri O . Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest 2020; 130(12): 6409–6416

[50] Pirro M , Ferri L , Piccioni L , Bellucci AM , Bartolucci F , Russo A , Piga A , Ciaramaglia PL , Lucangeli M , Russo AM , Cuzzocrea S , Evangelista M . What is the role of palmitoylethanolamide co-ultramicronized with luteolin on the symptomatology reported by patients suffering from long COVID? A retrospective analysis performed by a group of general practitioners in a real-life setting. Nutrients 2023; 15(17): 3701

[51] De Luca P , Camaioni A , Marra P , Salzano G , Carriere G , Ricciardi L , Pucci R , Montemurro N , Brenner MJ , Di Stadio A . Effect of ultra-micronized palmitoylethanolamide and luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells 2022; 11(16): 2552

[52] Ryu JK , Yan Z , Montano M , Sozmen EG , Dixit K , Suryawanshi RK , Matsui Y , Helmy E , Kaushal P , Makanani SK , Deerinck TJ , Meyer-Franke A , Rios Coronado PE , Trevino TN , Shin MG , Tognatta R , Liu Y , Schuck R , Le L , Miyajima H , Mendiola AS , Arun N , Guo B , Taha TY , Agrawal A , MacDonald E , Aries O , Yan A , Weaver O , Petersen MA , Meza Acevedo R , Alzamora MDPS , Thomas R , Traglia M , Kouznetsova VL , Tsigelny IF , Pico AR , Red-Horse K , Ellisman MH , Krogan NJ , Bouhaddou M , Ott M , Greene WC , Akassoglou K . Fibrin drives thromboinflammation and neuropathology in COVID-19. Nature 2024; 633(8031): 905–913

[53] Lau RI , Su Q , Lau ISF , Ching JYL , Wong MCS , Lau LHS , Tun HM , Mok CKP , Chau SWH , Tse YK , Cheung CP , Li MKT , Yeung GTY , Cheong PK , Chan FKL , Ng SC . A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2024; 24(3): 256–265

[54] Ranisavljev M , Stajer V , Todorovic N , Ostojic J , Cvejic JH , Steinert RE , Ostojic SM . The effects of 3-month supplementation with synbiotic on patient-reported outcomes, exercise tolerance, and brain and muscle metabolism in adult patients with post-COVID-19 chronic fatigue syndrome (STOP-FATIGUE): a randomized Placebo-controlled clinical trial. Eur J Nutr 2025; 64: 28

[55] Slankamenac J , Ranisavljev M , Todorovic N , Ostojic J , Stajer V , Candow DG , Ratgeber L , Betlehem J , Acs P , Ostojic SM . Eight-week creatine-glucose supplementation alleviates clinical features of long COVID. J Nutr Sci Vitaminol (Tokyo) 2024; 70(2): 174–178

[56] Charoenporn V , Tungsukruthai P , Teacharushatakit P , Hanvivattanakul S , Sriyakul K , Sukprasert S , Kamalashiran C , Tungsukruthai S , Charernboon T . Effects of an 8-week high-dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post-COVID syndrome: a randomized controlled trial. Psychiatry Clin Neurosci 2024; 78(10): 595–604

[57] Young TP , Erickson JS , Hattan SL , Guzy S , Hershkowitz F , Steward MDA . Single-blind, randomized, placebo controlled study to evaluate the benefits and safety of Endourage targeted wellness Formula C sublingual + drops in people with post-acute coronavirus disease 2019 syndrome. Cannabis Cannabinoid Res 2024; 9(1): 282–292

[58] Tosato M , Calvani R , Picca A , Ciciarello F , Galluzzo V , Coelho-Júnior HJ , Di Giorgio A , Di Mario C , Gervasoni J , Gremese E , Leone PM , Nesci A , Paglionico AM , Santoliquido A , Santoro L , Santucci L , Tolusso B , Urbani A , Marini F , Marzetti E , Landi F . Effects of L-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Nutrients 2022; 14(23): 4984

[59] Wood E , Hall KH , Tate W . Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers’. Chronic Dis Transl Med 2021; 7(1): 14–26

[60] Finnigan LEM , Cassar MP , Koziel MJ , Pradines J , Lamlum H , Azer K , Kirby D , Montgomery H , Neubauer S , Valkovič L , Raman B . Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine 2023; 59: 101946

[61] Tsuchida T , Hirose M , Inoue Y , Kunishima H , Otsubo T , Matsuda T . Relationship between changes in symptoms and antibody titers after a single vaccination in patients with long COVID. J Med Virol 2022; 94(7): 3416–3420

[62] Hohberger B , Harrer T , Mardin C , Kruse F , Hoffmanns J , Rogge L , Heltmann F , Moritz M , Szewczykowski C , Schottenhamml J , Kräter M , Bergua A , Zenkel M , Gießl A , Schlötzer-Schrehardt U , Lämmer R , Herrmann M , Haberland A , Göttel P , Müller J , Wallukat G . Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med (Lausanne) 2021; 8: 754667

[63] Hadanny A , Zilberman-Itskovich S , Catalogna M , Elman-Shina K , Lang E , Finci S , Polak N , Shorer R , Parag Y , Efrati S . Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial. Sci Rep 2024; 14(1): 3604

[64] Hollifield M , Cocozza K , Calloway T , Lai J , Caicedo B , Carrick K , Alpert R , Hsiao AF . Improvement in long-COVID symptoms using acupuncture: a case study. Med Acupunct 2022; 34(3): 172–176

[65] Ledford H . Long-COVID treatments: why the world is still waiting. Nature 2022; 608(7922): 258–260

RIGHTS & PERMISSIONS

Higher Education Press